PCRX vs ROST · P/E 174, rev $369.8M vs P/E 21, rev $22.75B
Pacira BioSciences, Inc. (PCRX) versus Ross Stores Inc (ROST) — a side-by-side from cached financials, not a winner call.
Pacira BioSciences, Inc. (PCRX) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Ross Stores Inc (ROST) is a apparel retail company listed on US.
Latest reported PCRX revenue for 2026-06-30 was $369.8M. Net income was $7.6M. PCRX currently screens at market cap $890.8M and trailing P/E 174.2.
Latest reported ROST revenue for 2026-01-31 was $22.75B. Net income was $2.15B. ROST currently screens at market cap $43.03B and trailing P/E 20.8.
PCRX currently screens at market cap $890.8M and trailing P/E 174.2. ROST currently screens at market cap $43.03B and trailing P/E 20.8.
Not investment advice. Open the PCRX and ROST stock pages for the full models.
Not investment advice.